These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 32423432)

  • 1. The association of depressive symptoms, personality traits, and sociodemographic factors with health-related quality of life and quality of life in patients with advanced-stage lung cancer: an observational multi-center cohort study.
    de Mol M; Visser S; Aerts J; Lodder P; van Walree N; Belderbos H; den Oudsten B
    BMC Cancer; 2020 May; 20(1):431. PubMed ID: 32423432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of low-grade adverse events and quality of life during chemotherapy determine patients' judgement about treatment in advanced-stage thoracic cancer.
    de Mol M; Visser S; den Oudsten BL; Lodder P; van Walree N; Belderbos H; Aerts JG
    Support Care Cancer; 2019 Sep; 27(9):3563-3572. PubMed ID: 30690684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
    Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Satisfaction of Patients With Advanced Non-Small-cell Lung Cancer Receiving Platinum-based Chemotherapy: Results From a Prospective Cohort Study (PERSONAL).
    Visser S; de Mol M; Cheung K; van Toor JJ; van Walree NC; Stricker BH; Den Oudsten BL; Aerts JGJV
    Clin Lung Cancer; 2018 Jul; 19(4):e503-e516. PubMed ID: 29705017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
    Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
    Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1).
    Hirsh V; Cadranel J; Cong XJ; Fairclough D; Finnern HW; Lorence RM; Miller VA; Palmer M; Yang JC
    J Thorac Oncol; 2013 Feb; 8(2):229-37. PubMed ID: 23328549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1-Expressing NSCLC.
    Barlesi F; Garon EB; Kim DW; Felip E; Han JY; Kim JH; Ahn MJ; Fidler MJ; Gubens MA; de Castro G; Surmont V; Li Q; Deitz AC; Lubiniecki GM; Herbst RS
    J Thorac Oncol; 2019 May; 14(5):793-801. PubMed ID: 30711649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional Study.
    Hechtner M; Eichler M; Wehler B; Buhl R; Sebastian M; Stratmann J; Schmidberger H; Gohrbandt B; Peuser J; Kortsik C; Nestle U; Wiesemann S; Wirtz H; Wehler T; Bals R; Blettner M; Singer S
    J Thorac Oncol; 2019 Mar; 14(3):420-435. PubMed ID: 30508641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety, depression and defense mechanisms associated with treatment decisional preferences and quality of life in non-metastatic breast cancer: a 1-year prospective study.
    Hyphantis T; Almyroudi A; Paika V; Degner LF; Carvalho AF; Pavlidis N
    Psychooncology; 2013 Nov; 22(11):2470-7. PubMed ID: 23712915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related Quality of Life and Pain in a Real-world Castration-resistant Prostate Cancer Population: Results From the PRO-CAPRI Study in the Netherlands.
    Kuppen MCP; Westgeest HM; van den Eertwegh AJM; Coenen JLLM; van Moorselaar RJA; van den Berg P; Geenen MM; Mehra N; Hendriks MP; Lampe MI; van de Luijtgaarden ACM; Peters FPJ; Roeleveld TA; Smilde TJ; de Wit R; van Oort IM; Gerritsen WR; Uyl-de Groot CA
    Clin Genitourin Cancer; 2020 Jun; 18(3):e233-e253. PubMed ID: 31883940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Comparison of WHOQOL-BREF with Disease Specific Heath Related Quality of Life Questionnaire in Irritable Bowel Syndrome.
    Jamali R; Biglari M
    Acta Med Iran; 2015 Nov; 53(11):717-24. PubMed ID: 26786994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of illness beliefs and chemotherapy impact on quality of life in Japanese and Dutch patients with breast or lung cancer.
    van der Kloot WA; Uchida Y; Inoue K; Kobayashi K; Yamaoka K; Nortier HW; Kaptein AA
    Chin Clin Oncol; 2016 Feb; 5(1):3. PubMed ID: 26932427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life, personality and choice of coping are related in renal cell carcinoma patients.
    Beisland E; Beisland C; Hjelle KM; Bakke A; Aarstad AK; Aarstad HJ
    Scand J Urol; 2015; 49(4):282-9. PubMed ID: 25515950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Evaluation of Health-Related Quality of Life in Patients With Multiple Myeloma From Germany.
    Engelhardt M; Ihorst G; Singh M; Rieth A; Saba G; Pellan M; Lebioda A
    Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e160-e175. PubMed ID: 33218965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in patients with advanced non-small cell lung cancer.
    Bozcuk H; Dalmis B; Samur M; Ozdogan M; Artac M; Savas B
    Cancer Nurs; 2006; 29(2):104-10. PubMed ID: 16565619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of change in symptoms, respiratory status, nutritional profile and quality of life on response to treatment for advanced non-small cell lung cancer.
    Mohan A; Singh P; Kumar S; Mohan C; Pathak AK; Pandey RM; Guleria R
    Asian Pac J Cancer Prev; 2008; 9(4):557-62. PubMed ID: 19256738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.
    Brown J; Thorpe H; Napp V; Fairlamb DJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG; Stephens RJ; Waller D; West P; Peake MD
    J Clin Oncol; 2005 Oct; 23(30):7417-27. PubMed ID: 16157935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial.
    Kubota K; Sakai H; Katakami N; Nishio M; Inoue A; Okamoto H; Isobe H; Kunitoh H; Takiguchi Y; Kobayashi K; Nakamura Y; Ohmatsu H; Sugawara S; Minato K; Fukuda M; Yokoyama A; Takeuchi M; Michimae H; Gemma A; Kudoh S;
    Ann Oncol; 2015 Jul; 26(7):1401-8. PubMed ID: 25908605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The determinants of health-related quality of life among patients with newly diagnosed lung cancer in Taiwan: A cross-sectional study.
    Liao CH; Yu S; Lin KC; Wu YC; Wang TJ; Wang KY
    J Chin Med Assoc; 2023 Mar; 86(3):338-344. PubMed ID: 36730003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life with second or third line
    Ponce Aix S; Talbot D; Govindan R; Dols MC; Postmus PE; Lewanski C; Bennouna J; Fischer JR; Juan-Vidal O; Stewart DJ; Ardizzoni A; Bhore R; Wolfsteiner M; Reck M; Ong TJ; Morgensztern D
    Future Oncol; 2020 Apr; 16(12):749-762. PubMed ID: 32228198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 39.